THE WORKFORCE AND COST IMPLICATIONS OF SUBSTITUTING NURSES AND PHARMACISTS FOR DOCTORS IN THE FOLLOW-UP OF PATIENTS WITH AIDS ON ANTIRETROVIRAL THERAPY IN UGANDA

Author(s)

Joseph B Babigumira, MBChB, MS, Student1, Barbara Castelnuovo, MD, Study Coordinator2, Mohamed Lamorde, MD, Scholar2, Alice Muwanga, MD, Doctor2, Andrew Kambugu, MBChB, MMed, Clinical Director2, Phillipa Easterbrook, PhD, Head of Research2, Louis Garrison, PhD, Professor of Pharmacy11University of Washington, Seattle, WA, USA; 2 Infectious Diseases Institute, Kampala, Uganda

Objective: To quantify the workforce and cost implications of routine doctor-intensive (DI), nurse-intensive (NI) and pharmacist-intensive (PI) ART follow-up algorithms for HIV/AIDS treatment at the Infectious Diseases Institute, a large urban HIV clinic in Kampala, Uganda. Methods: We performed a societal perspective cost analysis including health resource utilization and opportunity cost of patient waiting (PW) time. A time-motion survey was performed to estimate median health worker utilization (HWU) and PW times for different services. Unique personnel requirements were identified to determine hourly HWU per patient, which was multiplied by hourly wages for different cadres. PW times were multiplied by mean hourly wage for Ugandans. National workforce and cost implications were projected. Results: Median HWU and PW times per visit (hours) were 0.20 and 0.24 for triage nurses, 0.12 and 1.10 for doctors, 0.08 and 0.27 for pharmacists, and 0.13 and 0.05 for nurses. HWU time for refill pharmacists was 0.03 with no waiting. Hourly wages were: nurses-$4.6, doctors-$8.3, and pharmacists-$3.3. The average Ugandan hourly wage was $0.99. Total annual societal per-patient cost of follow-up was $45.2 for DI, $28.3 for NI and $16.3 for PI. Total projected national annual follow-up cost was $13.5 million for DI, $8.5 million for NI and $4.9 million for PI. Extrapolating to a national level, we project that the substitution of nurses or pharmacists for doctors would save 404 full-time-equivalent doctors per year, 18.4% of the current number practicing in Uganda. Conclusion: The use of NI and PI innovations as substitutes for DI follow-up results in substantial reductions in doctor demand and substantial societal cost savings. Since prior research suggests no adverse impact on adherence to drugs and follow-up of these innovations, serious consideration should be given to policy changes to adopt substituting for doctor for routine HIV follow-up care.

Conference/Value in Health Info

2008-05, ISPOR 2008, Toronto, Ontario, Canada

Value in Health, Vol. 11, No. 3 (May/June 2008)

Code

PIN9

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×